BIAL Announces Oral Presentation at GBA1 Meeting 2025 ...Middle East

PORTO, Portugal, June 2, 2025 /PRNewswire/ -- BIAL, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today announced that it will give an oral presentation on its potential disease-modifying compound, BIA 28-6156, at the GBA1 Meeting 2025 being...

Read More Details
Finally We wish PressBee provided you with enough information of ( BIAL Announces Oral Presentation at GBA1 Meeting 2025 )

Also on site :

• 7 pet-friendly Colorado hotels for your next getaway or roadtrip
• Chipotle’s new CEO is bringing back a missing ingredient to hit the chain’s next goal—raising annual sales per store to $4 million
• The Mid-Morning Habit Cardiologists Are Begging You to Never, Ever Do